Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
FY ’13 Budget: FDA, CDC
President Barack Obama has proposed a budget for the 2013 fiscal year that largely keeps growth slow and steady for key biopharma agencies, with exceptions. FDA would see its budgetary authority inch up by 0.4% to $2.517 billion. But when industry user fees are included, FDA’s total program spending would jump 17% to $4.486 billion. CDC would see its discretionary budget authority shrink by 11.6% or $664 million to $5.068 billion. After nondiscretionary spending is factored in, however, total CDC funding rises by 0.4% to $11.236 billion in FY ’13. What do you think?